CoreAge Rx vs LumiMeds
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and LumiMeds head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
LumiMeds
FDA warning letter, September 2025 — issued to Lumimeds. See the FDA's warning letter database.
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 63 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make LumiMeds a bad call — it's best for readers who can verify the complete commitment and reconcile flexible-cancellation marketing with the membership agreement. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | LumiMeds |
|---|---|---|
| Brief Score | 94/100 (A) | 63/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | Homepage advertises $89/month Compounded weekly injection; full fixed-term commitment, selected dose, supplied quantity and payment schedule unconfirmed. Earlier $133/month observation is historical. Membership terms reserve changes with 28-day notice and restrict early cancellation; $100 deduction may apply to eligible refunds. Pharmacy submission ends ordinary order cancellation. Full price detailsCompounded semaglutide injections offered; complete selected-term quote unknown; current homepage advertises $89/month but full commitment, payment schedule and supplied quantity are unconfirmed; earlier $133/month listing is historical |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | Homepage advertises $125/month Compounded weekly injection; complete commitment and supply unconfirmed. Price-lock marketing needs its governing conditions; earlier $133/month observation is historical. Fixed-term obligation can outlast installments. Non-approval exception and $100 cancellation/refund provisions differ from cancel-anytime marketing. Full price detailsCompounded tirzepatide injections offered; complete selected-term quote unknown; current homepage advertises $125/month but full commitment, payment schedule and supplied quantity are unconfirmed; earlier $133/month listing is historical |
| Coverage | US only; restrictions by state, confirmed at intake | Service is limited to eligible U.S. states under the terms; a complete current medication-specific state list was not established |
| Brand-name access | Not confirmed | A general reference to possible brand-name prescribing does not identify a current named branded GLP-1 program or price. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
LumiMeds: Advertised $89/$125 monthly rates need the complete commitment and supply. Fixed-term restrictions, price-change provisions and $100 cancellation deductions need reconciliation before payment.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.